Nicholas Segal serves as Executive at TherapeuticsMD, Inc., where they oversee executive responsibilities. Since joining the company, Nicholas Segal has executed 3 insider transactions totaling $1.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 26, 2014 involved selling 30,000 shares valued at $201.0K.
Nicholas Segal currently holds 215,485 shares of TherapeuticsMD, Inc. (TXMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nicholas Segal has been a net seller of TXMD stock. They have purchased $114.9K and sold $1.4M worth of shares.
Nicholas Segal's most recent insider trade was on Mar 26, 2014, when they sold 30,000 shares at $6.70 per share.
Get notified when new Form 4 filings are submitted
| $6.70 |
| Discretionary |
| Aug 26, 2013 | TXMD | $114.9K | Purchase | 74,128 | $1.55 | Discretionary |